Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Exactly Mikep109. I have heard all this rhetoric before from this government. Vaccines have done a great job but 30% of Sprinter trial is vaccinated patients. It will be the same with pills or whatever else they come up with. Big Pharma will cash in on whatever they can. However I do believe that RM has positioned this drug perfectly at the stage of disease which causes so many issues to society. Just waiting for the data to prove it.
Matml74 - I actually know that, but somehow thought algo trades only had the trade type code 'Algo' and not 'P Algo'. So got things mixed up a bit. Thanks anyway.
Interesting. In total there were 2,437 transactions today. 1,017 were algo trades and 1,358 were part of the protected portfolio transaction. That leaves 62 as other.
Alpha,
There was a large drop to 120p at end of September, approx 20 million shares traded over 4 days. I suspect mm's had to take a lot of that onto their books and offloaded today at a tidy profit.
Matterhorn, Algo trades are generally small and are computer generated algorithm trades. They are used by high frequency traders or can be used to force the SP for a low volume share like SNG in the direction the buyer or seller wants the price to be.
For example today between the times of 14:44:26 and 14:44:58 there were 68 algorithm trades of 100 shares each reported at 166. When you see unusual trading like this you have to ask yourself the question why?!! In the 5 minutes after this there were approx £170k worth of trades put through at just under 166.
Adding to Matml74's post from earlier today.
12m shares traded today of which 7.75m were 'P' (protected portfolio trades) and 2m were 'P Algo' trades. I suspect the 'P Algo' trades are protected too? Need someone to opine on that. Tried finding a definition list for the trade types, but couldn't find a comprehensive one.
Other noticeable trade types were:
NLIQ P: 620k
PRIC P: 560k
CANC P: 32k
The problem for us is the 2 drugs in question come from Merck and Pfizer....they will literally have the ear of the PM or President of most countries....it is not a level playing field
It is 100% possible that a more effective drug such as SNG never gets to patients whereas it is all but guaranteed that if Big Pharma brings a less effective drug they will get approval
Somebody like Sir SH needs to bang the heads of the regulators and Gov together !
No drug will be saving lives until it’s approved
That applies to Merck
Pfizer or Synairgen
This is what our friend Peter Horby said about Molnupiravir
The proportional reduction in the risk of hospitalisation or death is impressive, but it is important to remember that the absolute risks were 14% reduced to 7%, so quite a lot of people need to be treated to prevent one hospitalisation or death.
Hardly a ringing endorsement
its definitely not a rotten end to the day. As I mentioned before, there was no way SJ was going to mention us today, he will in Jan/Feb though and that is all that matters. I still expect the SP to hover around the 150-170 mark until then. We are completely de-risked here, I cannot remember a time where I was this confident on PIII results and todays new cemented that further.
My advice, keep adding on any dips and reap the rewards Q1 next year.
Its hardly a rotten end of the day doc, still up 13%
The science pretty much shows this already. It's just being flippin' ignored!
The Merck drug needs to be taken in the first 5 days when in most people isn’t clear if they’ll progress to severe symptoms. Most of these patients turning up at hospital are only reporting when they’re so ill they have to go to hospital which is way too late for this drug
The Pfizer drug hasn’t been shown in to an effective drug in COVID hospitalised patients.
By the time MHRA approve either of these drugs the science will show SNG001 is the most effective treatment in non hospital and hospitalised patients
Thanks Matml - Yes Skeletor has alluded to my follow up question as to how come there is suddenly so much share liquidity and available sellers willing to give up their shares.
It would make sense in my head more if the volume was more steady/typical and the SP stayed constant to fill a big II order - but I'm puzzled why the sudden flood of shares when its not an earth shattering rise that could precede a fall and people want to crystallise their profits.
Personally, with further Activ2 detail potentially 'imminent' and then LPD for Sprinter in the next few weeks I'm going to continue patiently waiting for continued rises - even if today wasn't as explosive as hoped.
Pretty sure we're run by outsourced management consulting firms e.g. BCG - Sajida is just a mouthpiece
Is it just me or do these Govt puppets give you no confidence whatsoever ?
If he says ' loved ones' one more time I may vomit .
A few more large after hour trades. Surely these can't be all sells. Definitely buys and accumulated by IIs.
20-Oct-21 17:04:46 164.888 322,914 Sell* 532.45k O
20-Oct-21 17:00:41 164.88812 98,417 Sell* 162.28k O
20-Oct-21 16:44:05 165.99823 95,003 Sell* 157.70k O
20-Oct-21 16:43:43 166.01184 95,490 Sell* 158.52k O
20-Oct-21 16:43:27 166.01694 47,222 Sell* 78.40k
But for that to work there has to be willing sellers at the held back price... which then suggests that the price in actual fact is not really being held back... supply is meeting demand.
For ****s sake
he didn't
He better mention Synairgen. He just better!
Can someone politely suggest to Sajid Javid take a trip down to Southampton..
Really useful info, thanks Matml74
Alpha,
Many of the large trades today, for example the two below were 'single protected transaction' "non protected portfolio' which means.....
"A protected transaction occurs when a large order is going through the market. The buyer (or seller) may wish to keep the order anonymous from the rest of the market as the size of the order could greatly alter the price of the stock." A market maker on a non protected portfolio transaction can also make the transaction at an agreed discount to the market price.
So basically the share price has been held (manipulated IMO) so that this large order could be put through the market at around 165/166. There were over 2m shares traded today in trade sizes above 50,000 shares at an average of 165.38. Many of these were single protected transactions!
So basically if you have enough money you can dictate the trade price you want and then for everyone else you take what you are offered! Has been happening with this share all year and the reason Polygon have been able to accumulate 12% of the company without increasing the share price at all.
20-Oct-21 10:34:36 165.50 125,000 Sell* 165.60 166.90 206.88k
20-Oct-21 10:34:19 165.50 125,000 Sell* 165.60 166.80 206.88k
The UK government has already proved it doesn’t support the UK pharmaceutical or diagnostic industry .